Henry Schein, Inc. (HSIC) All Metrics
HSIC Valuation Metrics
HSIC Stock Price Metrics
HSIC Dividend Metrics
HSIC Growth Rate Metrics
HSIC Discounted Cash Flow Metrics
| Fair Value Price | $80.95 |
| Margin of Safety | 2.90% |
HSIC Revenue Metrics
HSIC PE Ratio Metrics
| PE Ratio | 23.77 |
| PE Ratio Avg TTM | 22.87 |
| PE Ratio Avg 3Y | 22.91 |
| Current VS TTM Avg | +3.94% |
| Current VS 3Y Avg | +3.77% |
| Current VS 5Y Avg | +11.40% |
HSIC PS Ratio Metrics
| PS Ratio | 0.68 |
| PS Ratio Avg TTM | 0.68 |
| PS Ratio Avg 3Y | 0.72 |
| Current VS TTM Avg | +0.21% |
| Current VS 3Y Avg | -5.82% |
| Current VS 5Y Avg | -13.67% |
HSIC PB Ratio Metrics
| PB Ratio | 2.80 |
| PB Ratio Avg TTM | 2.64 |
| PB Ratio Avg 3Y | 2.64 |
| Current VS TTM Avg | +6.12% |
| Current VS 3Y Avg | +6.18% |
| Current VS 5Y Avg | -1.26% |
HSIC Price to Free Cash Flow Ratio Metrics
| PFCF Ratio | 21.18 |
| PFCF Ratio Avg TTM | 20.86 |
| PFCF Ratio Avg 3Y | 20.10 |
| Current VS TTM Avg | +1.53% |
| Current VS 3Y Avg | +5.38% |
| Current VS 5Y Avg | +11.33% |
HSIC Debt to Equity Ratio Metrics
| Debt/Equity Ratio | 1.14 |
| Debt/Equity Ratio Avg TTM | 0.99 |
| Debt/Equity Ratio Avg 3Y | 0.79 |
| Current VS TTM Avg | +14.57% |
| Current VS 3Y Avg | +43.85% |
| Current VS 5Y Avg | +78.59% |
HSIC PEG Ratio Metrics
| PEG Ratio | 3.23 |
| PEG Ratio Avg TTM | - |
| PEG Ratio Avg 3Y | - |
| Current VS TTM Avg | - |
| Current VS 3Y Avg | - |
| Current VS 5Y Avg | +83.52% |
HSIC FCF Yield
| FCF Yield | 4.72% |
| FCF Yield Avg TTM | 4.92% |
| FCF Yield Avg 3Y | 5.12% |
| Current VS TTM Avg | -4.09% |
| Current VS 3Y Avg | -7.87% |
| Current VS 5Y Avg | -12.19% |
HSIC Earnings Yield
| Earnings Yield | 4.21% |
| Earnings Yield Avg TTM | 4.39% |
| Earnings Yield Avg 3Y | 4.35% |
| Current VS TTM Avg | -4.04% |
| Current VS 3Y Avg | -3.28% |
| Current VS 5Y Avg | -11.39% |
HSIC EV/EBIT Ratio Metrics
| Ev/Ebit Ratio | 17.01 |
| Ev/Ebit Ratio Avg TTM | 15.78 |
| Ev/Ebit Ratio Avg 3Y | 16.36 |
| Current VS TTM Avg | +7.80% |
| Current VS 3Y Avg | +3.97% |
| Current VS 5Y Avg | +10.73% |
HSIC EV/EBITDA Ratio Metrics
| Ev/Ebitda Ratio | 12.72 |
| Ev/Ebitda Ratio Avg TTM | 12.39 |
| Ev/Ebitda Ratio Avg 3Y | 12.93 |
| Current VS TTM Avg | +2.64% |
| Current VS 3Y Avg | -1.65% |
| Current VS 5Y Avg | +1.94% |
HSIC EV/Assets Ratio Metrics
| Ev/Assets Ratio | 1.13 |
| Ev/Assets Ratio Avg TTM | 1.10 |
| Ev/Assets Ratio Avg 3Y | 1.14 |
| Current VS TTM Avg | +2.57% |
| Current VS 3Y Avg | -0.91% |
| Current VS 5Y Avg | -10.82% |
HSIC EV/Sales Ratio Metrics
| Ev/Sales Ratio | 0.95 |
| Ev/Sales Ratio Avg TTM | 0.94 |
| Ev/Sales Ratio Avg 3Y | 0.94 |
| Current VS TTM Avg | +1.47% |
| Current VS 3Y Avg | +1.20% |
| Current VS 5Y Avg | +0.14% |
HSIC Current Ratio Metrics
| Current Ratio | 1.38 |
| Current Ratio Avg TTM | 1.40 |
| Current Ratio Avg 3Y | 1.56 |
| Current VS TTM Avg | -1.43% |
| Current VS 3Y Avg | -11.82% |
| Current VS 5Y Avg | -13.66% |
HSIC Quick Ratio Metrics
| Quick Ratio | 0.76 |
| Quick Ratio Avg TTM | 0.77 |
| Quick Ratio Avg 3Y | 0.86 |
| Current VS TTM Avg | -1.30% |
| Current VS 3Y Avg | -11.88% |
| Current VS 5Y Avg | -14.12% |
HSIC ROIC Metrics
| ROIC | 6.58% |
| ROIC Avg 3Y | 7.75% |
| ROIC Avg 5Y | 8.24% |
| Current VS 3Y Avg | -15.04% |
| Current VS 5Y Avg | -20.13% |
| Current VS 10Y Avg | -28.27% |
HSIC Return on Assets Metrics
| ROA | 3.55 |
| ROA Avg TTM | 3.68 |
| ROA Avg 3Y | 4.39 |
| Current VS TTM Avg | -3.66% |
| Current VS 3Y Avg | -19.09% |
| Current VS 5Y Avg | -29.19% |
HSIC Return on Equity Metrics
| ROE | 12.27 |
| ROE Avg TTM | 11.88 |
| ROE Avg 3Y | 12.69 |
| Current VS TTM Avg | +3.28% |
| Current VS 3Y Avg | -3.29% |
| Current VS 5Y Avg | -9.09% |
HSIC Net Profit Margin Metrics
| Net Profit Margin | 3.02% |
| Net Profit Margin Avg TTM | 3.05% |
| Net Profit Margin Avg 3Y | 3.43% |
| Current VS TTM Avg | -0.98% |
| Current VS 3Y Avg | -11.95% |
| Current VS 5Y Avg | -20.25% |
Last Updated: Tuesday, June 23, 2026
About Henry Schein, Inc.
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Andrea Albertini